Bruno Julianne bought CRSP
March 10, 2025 · Form 4 insider transaction
Bruno Julianne bought 2,399 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,399
Price
N/A
Total value
N/A
InsiderBruno Julianne
RoleOfficer, Director
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateMarch 10, 2025
Filing dateMarch 12, 2025
Shares owned after9,461
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.